세계의 마이크로톰 시장 : 시장 인사이트, 경쟁 구도, 시장 예측(2032년)

Microtome Market by Product (Microtome [Rotary Microtome, Vibrating Microtome, and Others] and Accessories [Blades and Knives, Cooling Clamp, and Others]), Technology (Fully Automated, Semi-Automated, and Manual), End-User (Hospitals, Diagnostic Clinics, Academic and Research Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing cases of chronic disorders, increase in research and development activities, among others globally.

The microtome market is estimated to grow at a CAGR of 6.13% during the forecast period from 2025 to 2032. The demand for microtomes is primarily being boosted by the increasing cases of chronic disorders such as cancer, infectious disease, cardiovascular diseases, including atherosclerosis, myocardial infarction, and cardiomyopathies, respiratory disorders like asthma, chronic obstructive pulmonary disease (COPD), and others. Additionally, the expansion of biomedical research and pharmaceutical development activities worldwide is fueling the demand for microtomes. Researchers require high-quality tissue sections for molecular diagnostics, drug discovery, and personalized medicine, thus boosting the market for microtomes during the forecast period from 2025 to 2032.

Microtome Market Dynamics:

According to data provided by the International Agency for Research on Cancer (2024), in 2022, approximately 20 million new instances of cancer were registered globally. Additionally, as per the same source, lung cancer accounted for 2.5 million new cases globally, of all the registered new cancer cases, making it the most common cancer. Next in order of incidence were breast cancer with 2.3 million cases, colon cancer with 1.9 million cases, and stomach cancer with 0.97 million cases globally.

The Global Cancer Observatory (2024) estimated that the new instances of cancer globally would range from 20 million to 24.1 million by the year 2030. Moreover, it stated that Asia accounted for 9,826,539 cancer cases, Europe accounted for 4,471,422 cancer cases, LAC accounted for 1,551,060 cancer cases, and Africa accounted for 1,185,216 cancer cases.

Since cancer diagnosis and treatment rely heavily on accurate tissue examination, the rising cancer rates necessitate the widespread use of microtomes to prepare high-quality tissue sections for microscopic analysis. This surge in cancer cases translates into a larger market for microtomes.

Additionally, during outbreaks of infectious diseases such as tuberculosis, hepatitis, COVID-19, and fungal infections, histopathological evaluation of biopsied tissues becomes essential to identify the pathogen, assess the extent of tissue damage, and monitor disease progression. According to the data provided by the World Health Organization, in 2023, an estimated 10.8 million people fell ill with TB worldwide, including 6.0 million men, 3.6 million women, and 1.3 million children. Additionally, as per the same source, in 2022, an estimated 254 million people were living with hepatitis B and 50 million people were living with hepatitis C worldwide, and 6000 people were newly infected with viral hepatitis each day. Microtomes are crucial in preparing thin, uniform tissue sections that are stained and examined under microscopes for definitive diagnosis, thereby boosting the overall market of microtomes.

Therefore, all the above-mentioned factors are expected to drive the market for microtomes during the given forecast period.

However, the availability of alternative sample preparation technologies, such as cryo-sectioning and laser microdissection, could reduce the reliance on traditional microtomes, acting as factors that are expected to limit their end-user base, thus restricting the growth of the microtome market during the forecast period.

Microtome Market Segment Analysis:

Microtome Market by Product (Microtome [Rotary Microtome, Vibrating Microtome, and Others] and Accessories [Blades and Knives, Cooling Clamp, and Others]), Technology (Fully Automated, Semi-Automated, and Manual), End-User (Hospital, Diagnostic Clinics, Academic and Research Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the technology segment of the microtome market, the fully automated category of microtome is estimated to amass a significant revenue share in the microtome market in 2024. This can be attributed to the large patient population associated with various chronic disorders and the presence of a variety of products available to this category.

Fully automated microtomes offer several advantages and diverse applications, significantly enhancing the field of histopathology. Their primary benefits are to produce consistent high quality tissue sections with minimal user intervention, ensuring precision and reproducibility. This automation reduces the risk of human error and variability, which is crucial for accurate diagnosis.

In terms of applications, fully automated microtomes are invaluable in cancer diagnostics, where they provide fine tissue sections needed for detailed examination of tumor morphology and margins. They are also extensively used in research settings to study disease mechanisms at the cellular level, contributing to the development of new treatments and therapies. These advanced instruments are employed in various medical fields, including neuropathology, dermatopathology, and cardiovascular pathology, where precise tissue sectioning is critical for studying complex structures and diagnosing conditions.

Additionally, the presence of a huge number of commercially available fully automated systems and the increasing demand for digitalization in tissue diagnostic procedures are some of the crucial factors anticipated to boost the market in the next few years. Some of the key automated products include Microtome A550, Tissue-Tek Genie, and Leica Biosystems HistoCore AUTOCUT 2550.

Therefore, the various advantages and applications provided by fully automated microtomes will contribute to the growth of this category, thereby driving the growth of the overall microtome market during the forecast period.

North America is expected to dominate the overall microtome market:

North America is expected to account for the highest proportion of the microtome market in 2024, out of all regions. This is owing to the continual increase in cancer cases and infectious diseases in the North America region. Moreover, the high-end medical infrastructure paired with readily available high-tech equipment, expanding prospects for sophisticated cancer diagnostic testing and screening, favorable reimbursement policies for pathology labs, rise in healthcare spending, presence of a large number of market players in the region are expected to drive the growth of the microtome market in North America.

The National Cancer Institute (2024) estimated that 2 million new cases of cancer will be diagnosed in the US by the end of 2024. Furthermore, it was estimated that prostate, lung, and colorectal cancers were expected to represent approximately 48% of all cancer diagnoses in men. The most prevalent cancers are breast, lung, and colorectal, which are expected to account for about 51% of all new cancer diagnoses.

According to Global Cancer Observatory's data (2024), in 2022, the US represented 89.1% of all cancer cases, and Canada represented 10.9% of all cancer cases. The reliance on microtomes for accurate tissue sectioning in cancer diagnosis and research is paramount. Microtomes are essential for producing high-quality tissue samples for identifying cancer types, understanding disease progression, and tailoring treatment plans. Consequently, the rising instances of cancer catalyze the demand for microtomes, hence propelling market growth.

According to the recently updated data provided by the Centers for Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. The high incidence of myocardial infarctions necessitates extensive histological examination of cardiac tissues to understand the underlying causes. Microtomes are essential in preparing thin, detailed sections of heart tissue for microscopic analysis, enabling pathologists to examine cellular structures, detect abnormalities, and evaluate the effectiveness of treatment, therefore boosting its market growth.

According to the American Lung Association data updated in April 2024, it stated that more than 34 million people were living in the US with chronic lung diseases like asthma and COPD. These disorders underscore the growing need for microtomes in diagnostic pathology because of their ability to produce high-quality lung tissue sections for microscopic analysis, which is vital for diagnosing, understanding, and treating these conditions, consequently boosting the market for microtomes.

Thus, due to the interplay of all the above-mentioned factors, it will lead to an increase in the North America microtome market growth during the forecast period from 2025 to 2032.

Microtome Market Key Players:

Some of the key market players operating in the microtome market include Thermo Fisher Scientific Inc., AGD Biomedicals Pvt. Ltd., SLEE medical GmbH, Diapath S.p.A., Leica Biosystems Nussloch GmbH, Green Leaf Scientific, MEDITE Medical GmbH, LLS ROWIAK LaserLabSolutions GmbH, Amos Scientific PTY. LTD, RWD Life Science Co., Sakura Finetek, Boeckeler Instruments, Inc., HACKER Instruments & Industries Inc., microTec Laborgerate GmbH, Bright Instrument Co Limited, JINHUA YIDI MEDICAL APPLIANCES CO., LTD, FEATHER Safety Razor Co., Ltd., Precisionary Instruments, Powered Milestone Srl, Weinkauf Medizintechnik, and others.

Recent Developmental Activities in the Microtome Market:

• In February 2023, Precisionary Instruments launched a brand new line of rotatory microtomes and offered 3 models for the same; RF-600: Manual model, RF-800: Semi-automated model, RF-1000: Fully automated model.

Key takeaways from the microtome market report study

• Market size analysis for current microtome market size (2024), and market forecast over 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the global microtome market
• Various opportunities available for the other competitors in the microtome market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current microtome market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for microtome market growth in the future?

Target audience who can benefit from this microtome market report study

• Microtome product providers
• Research organizations and consulting companies
• Microtome-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in microtomes
• Various end-users who want to know more about the microtome market and the latest technological developments in the microtome market.

Frequently Asked Questions for the Microtome Market:

1. What is a microtome?

• Microtomes are specialized devices designed to create thin, uniform sections of tissue or other samples, typically ranging from a few micrometers to tens of micrometers in thickness.

2. What is the market for microtomes?

• The microtome market is estimated to grow at a CAGR of 6.13% during the forecast period from 2025 to 2032.

3. What are the drivers for the global microtome market?

• The microtome market is primarily being boosted by the increasing cases of chronic disorders such as cancer, infectious diseases, cardiovascular diseases, including atherosclerosis, myocardial infarction, and cardiomyopathies, respiratory disorders like asthma, chronic obstructive pulmonary disease (COPD), among others. Additionally, the expansion of biomedical research and pharmaceutical development activities worldwide is fueling the demand for microtomes. Researchers require high-quality tissue sections for molecular diagnostics, drug discovery, and personalized medicine, thus boosting the market for microtomes during the forecast period from 2025 to 2032.

4. Who are the key players operating in the microtome market?

• Some of the key market players operating in microtome include Thermo Fisher Scientific Inc., AGD Biomedicals Pvt. Ltd., SLEE medical GmbH, Diapath S.p.A., Leica Biosystems Nussloch GmbH, Green Leaf Scientific, MEDITE Medical GmbH, LLS ROWIAK LaserLabSolutions GmbH, Amos Scientific PTY. LTD, RWD Life Science Co, Sakura Finetek, Boeckeler Instruments, Inc., HACKER Instruments & Industries Inc., microTec Laborgerate GmbH, Bright Instrument Co Limited, JINHUA YIDI MEDICAL APPLIANCES CO., LTD, FEATHER Safety Razor Co., Ltd., Precisionary Instruments, Powered Milestone Srl, Weinkauf Medizintechnik, and others.

5. Which region has the highest share in the microtome market?

• North America is expected to account for the highest proportion of the microtome market in 2024, out of all regions. This is owing to the continual increase in cancer cases and infectious diseases in the North America region. Moreover, the high-end medical infrastructure paired with readily available high-tech equipment, expanding prospects for sophisticated cancer diagnostic testing and screening, favorable reimbursement policies for pathology labs, a rise in healthcare spending, presence of a large number of market players in the region are expected to drive the growth of the microtome market in North America.

Table of Contents

1. Microtome Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Microtome Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Microtome Market Key Factors Analysis

• 5.1. Microtome Market Drivers
  • 5.1.1. Growing cases of chronic disorders
  • 5.1.2. Rise in research and development activities
• 5.2. Microtome Market Restraints and Challenges
  • 5.2.1. Availability of alternative sample preparation technologies, such as cryo-sectioning and laser microdissection
• 5.3. Microtome Market Opportunities
  • 5.3.1. Development of AI-integrated microtomes for efficiency, fewer human errors, and better reproducibility in tissue sectioning

6. Microtome Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Microtome Market Assessment

• 7.1. By Product
  • 7.1.1. Devices
    • 7.1.1.1. Rotary Microtome
    • 7.1.1.2. Vibrating Microtome
    • 7.1.1.3. Others
  • 7.1.2. Accessories
    • 7.1.2.1. Blades and Knives
    • 7.1.2.2. Cooling Clamp
    • 7.1.2.3. Others
• 7.2. By Technology
  • 7.2.1. Fully Automated
  • 7.2.2. Semi-Automated
  • 7.2.3. Manual
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Diagnostic Clinics
  • 7.3.3. Academic and Research Laboratories
  • 7.3.4. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Microtome Market Size in USD million (2022-2032)
    • 7.4.1.2. Canada Microtome Market Size in USD million (2022-2032)
    • 7.4.1.3. Mexico Microtome Market Size in USD million (2022-2032)
  • 7.4.2. Europe
    • 7.4.2.1. France Microtome Market Size in USD million (2022-2032)
    • 7.4.2.2. Germany Microtome Market Size in USD million (2022-2032)
    • 7.4.2.3. United Kingdom Microtome Market Size in USD million (2022-2032)
    • 7.4.2.4. Italy Microtome Market Size in USD million (2022-2032)
    • 7.4.2.5. Spain Microtome Market Size in USD million (2022-2032)
    • 7.4.2.6. Rest of Europe Microtome Market Size in USD million (2022-2032)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Microtome Market Size in USD million (2022-2032)
    • 7.4.3.2. Japan Microtome Market Size in USD million (2022-2032)
    • 7.4.3.3. India Microtome Market Size in USD million (2022-2032)
    • 7.4.3.4. Australia Microtome Market Size in USD million (2022-2032)
    • 7.4.3.5. South Korea Microtome Market Size in USD million (2022-2032)
    • 7.4.3.6. Rest of Asia-Pacific Microtome Market Size in USD million (2022-2032)
  • 7.4.4. Rest of the World (RoW)

8. Microtome Market Company and Product Profiles

• 8.1. Thermo Fisher Scientific Inc
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. AGD Biomedicals Pvt. Ltd.
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. SLEE medical GmbH
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Diapath S.p.A.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Leica Biosystems Nussloch GmbH
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Green Leaf Scientific
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. MEDITE Medical GmbH
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. LLS ROWIAK LaserLabSolutions GmbH
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Amos Scientific PTY. LTD
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. RWD Life Science Co
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Sakura Finetek
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Boeckeler Instruments, Inc.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. HACKER Instruments & Industries Inc
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. microTec Laborgerate GmbH
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Bright Instrument Co Limited.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. JINHUA YIDI MEDICAL APPLIANCES CO., LTD
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. FEATHER Safety Razor Co., Ltd
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Precisionary Instruments
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Powered Milestone S.r.l.
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Weinkauf Medizintechnik
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us